IONS FY 2023 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$13B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$788M+34.1% YoY

Gross Profit

$779M98.8% margin

Operating Income

-$354M-44.9% margin

Net Income

-$366M-46.5% margin

EPS (Diluted)

$-2.56

Cash Flow

Operating Cash Flow

-$308M

Free Cash Flow

-$336M

Stock-Based Comp.

$106M

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.6B

Stockholders' Equity

$387M

Cash & Equivalents

$399M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$788M	$587M	+34.1%
Gross Profit	$779M	$573M	+35.8%
Operating Income	-$354M	-$410M	+13.8%
Net Income	-$366M	-$270M	-35.8%